+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Anatomic Pathology Market - Global Forecast 2026-2032- Product Image
Anatomic Pathology Market - Global Forecast 2026-2032- Product Image
Sale

Anatomic Pathology Market - Global Forecast 2026-2032

  • Report

  • 189 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 4896599
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Anatomic Pathology Market is projected to reach USD 44.80 Billion in 2026. It is expected to continue growing at a CAGR of 8.98%, reaching USD 75.43 Billion by 2032.

Anatomic pathology sits at the center of cancer diagnosis, tissue-based disease characterization, transplant evaluation, inflammatory disease workups, and precision medicine. The discipline spans histopathology, cytopathology, immunohistochemistry, in situ hybridization, molecular pathology, autopsy pathology, and surgical pathology workflows that convert tissue specimens into clinically actionable diagnoses.

Demand is structurally supported by rising cancer incidence, aging populations, and the continued expansion of biomarker-driven oncology. The International Agency for Research on Cancer reported about 20 million new cancer cases and 9.7 million cancer deaths worldwide in 2022, reinforcing the indispensable role of pathology laboratories in early detection, tumor classification, staging, grading, and therapy selection.

The market is also being reshaped by digital pathology, laboratory automation, companion diagnostics, and artificial intelligence-enabled image analysis. Health systems and diagnostic networks are prioritizing turnaround time, quality assurance, pathologist productivity, integrated reporting, and tissue stewardship as specimen volumes increase and subspecialty expertise remains unevenly distributed across geographies.

Transformative Shifts in the Anatomic Pathology Landscape

The most important shift in anatomic pathology is the movement from microscope-centered workflows to data-rich diagnostic ecosystems. Whole slide imaging, laboratory information systems, image management platforms, and interoperable reporting tools are enabling remote review, tumor boards, education, archiving, and quality control across distributed networks.

Precision oncology is another major force. Immunohistochemistry, fluorescence in situ hybridization, next-generation sequencing triage, and companion diagnostic testing are increasingly embedded in routine tissue workflows. This is raising expectations for standardized pre-analytics, validated assays, tissue stewardship, and faster reflex testing pathways that preserve limited biopsy material.

Regulation is becoming more consequential. In the United States, CLIA oversight, College of American Pathologists accreditation, and the FDA's 2024 final rule on laboratory developed tests are influencing validation, documentation, and risk management. In Europe, the In Vitro Diagnostic Regulation is reshaping conformity assessment and evidence expectations for diagnostic products used in pathology laboratories.

Cumulative Impact of Artificial Intelligence in Anatomic Pathology

Artificial intelligence is adding cumulative value across anatomic pathology rather than replacing pathologists. AI-assisted tools are being applied to case prioritization, mitotic counting, tumor detection, biomarker quantification, quality checks, workload balancing, and research-grade feature extraction from whole slide images.

Regulatory milestones have validated the clinical direction of the field. The U.S. Food and Drug Administration authorized the first whole slide imaging system for primary diagnostic use in 2017, and subsequent clearances for AI-assisted pathology applications have demonstrated growing acceptance of software as a medical device when supported by analytical and clinical validation.

The cumulative impact is operational and clinical. AI can reduce repetitive measurement burden, flag regions of interest, improve reproducibility in quantitative assays, and support subspecialty consultation in underserved areas. However, adoption depends on scanner standardization, data governance, cybersecurity, algorithm monitoring, bias assessment, pathologist oversight, and clear reimbursement or productivity justification.

Key Regional Insights Across Global Anatomic Pathology

North America remains a leading region for anatomic pathology because of high cancer screening uptake, mature hospital networks, reference laboratory scale, CAP-accredited quality systems, and early adoption of digital pathology. The United States drives much of the regional momentum through oncology diagnostics, academic medical centers, laboratory developed testing expertise, and reference laboratory networks, while Canada emphasizes publicly funded cancer care pathways, provincial pathology modernization, and quality-based diagnostic access.

Europe combines strong academic pathology expertise with regulatory transformation under the EU In Vitro Diagnostic Regulation. Germany, France, Italy, Spain, and the United Kingdom are advancing cancer diagnostics, biobanking, digital health infrastructure, and genomics-enabled care, although procurement cycles, workforce pressures, and data protection requirements can slow implementation. Asia-Pacific is expanding as China, India, Japan, South Korea, Australia, and ASEAN health systems address growing cancer burdens, urban hospital capacity, organized screening initiatives, and the need for standardized pathology quality.

Latin America, the Middle East, and Africa show rising need for tissue diagnostics tied to oncology expansion, infectious disease pathology, and increasing use of immunohistochemistry and molecular testing, but access remains uneven. Brazil and Mexico anchor Latin American demand through large public and private healthcare networks, Middle Eastern countries are investing in tertiary care, oncology centers, and laboratory accreditation, and African markets are focused on workforce development, sample logistics, external quality assessment, and regional reference testing models to improve access to reliable anatomic pathology services.

Key Group Insights for Anatomic Pathology Markets

ASEAN is gaining importance as Indonesia, Thailand, Vietnam, Malaysia, the Philippines, and Singapore expand hospital capacity and cancer care networks. Singapore acts as a regional hub for advanced diagnostics, digital health, and clinical research, while larger ASEAN markets require scalable pathology solutions that address affordability, workforce shortages, quality standardization, and specimen transport from secondary cities to centralized laboratories.

The GCC is investing in advanced tertiary care, oncology centers, laboratory accreditation, and digital health platforms, making it a significant corridor for premium pathology instrumentation, outsourced diagnostic partnerships, and quality-led modernization. The European Union is shaped by IVDR compliance, cross-border research programs, cancer mission initiatives, and strong public health systems, creating demand for validated diagnostics, traceable workflows, interoperable data systems, and evidence-based digital pathology adoption.

BRICS countries represent high-volume pathology environments because Brazil, Russia, India, China, and South Africa combine large patient populations with expanding oncology infrastructure and variable access to subspecialty expertise. G7 markets remain innovation leaders in digital pathology, molecular integration, clinical validation, and AI governance. NATO countries overlap substantially with advanced North American and European diagnostic systems, where resilience, cybersecurity, continuity planning, and secure medical data infrastructure are increasingly relevant to laboratory modernization.

Key Country Insights in Anatomic Pathology

The United States is the most influential country market, supported by large cancer care networks, commercial and academic reference laboratories, CLIA-certified testing, CAP accreditation, and strong adoption of companion diagnostics. Canada prioritizes centralized cancer programs, provincial quality standards, and equitable diagnostic pathways, while Mexico and Brazil are expanding private and public diagnostic capacity to address rising oncology needs across large and geographically diverse populations.

In Europe, the United Kingdom has invested in genomics, cancer diagnostic capacity, and digital pathology initiatives through the National Health Service, while Germany benefits from advanced laboratory infrastructure, strong medical technology adoption, and established pathology expertise. France, Italy, and Spain combine universal health systems with active cancer screening, hospital-based pathology networks, and increasing interest in molecular pathology, while Russia maintains demand through large tertiary hospitals and oncology centers despite procurement and geopolitical constraints.

China and India are high-priority anatomic pathology markets due to large disease burdens, hospital expansion, growing cancer screening activity, and increasing use of immunohistochemistry, histochemistry, and molecular pathology. Japan and South Korea are advanced markets with strong cancer diagnostics, automation, digital health capacity, and precision medicine infrastructure, while Australia benefits from organized cancer screening, high-quality pathology standards, accreditation culture, and regional leadership in digital health implementation.

Actionable Recommendations for Anatomic Pathology Leaders

Industry leaders should prioritize end-to-end workflow modernization rather than isolated technology purchases. Successful programs link specimen tracking, grossing, tissue processing, staining, slide scanning, reporting, archiving, and quality management into measurable productivity, turnaround time, and diagnostic quality outcomes.

Vendors and laboratories should invest in regulatory-grade validation, cybersecurity, interoperability, and pathologist-centered design. AI deployment should begin with high-value use cases such as triage, quality control, biomarker quantification, and workload optimization, with post-implementation monitoring, documented performance metrics, and transparent governance.

Commercial strategies should be region-specific. Mature markets need differentiated digital pathology platforms, automation, integrated molecular workflows, and evidence-based AI, while emerging markets need affordable instruments, training, remote consultation networks, external quality assessment, and accredited reference laboratory partnerships that improve access without compromising diagnostic quality.

Research Methodology for Anatomic Pathology Analysis

This executive summary is based on secondary research from publicly available and authoritative sources, including the World Health Organization, International Agency for Research on Cancer, U.S. Food and Drug Administration, Centers for Medicare & Medicaid Services, College of American Pathologists, European Commission, national cancer agencies, peer-reviewed literature, and major health system publications.

The analysis evaluates market drivers, regulatory developments, technology adoption, regional health infrastructure, workforce considerations, and country-level diagnostic capacity. Insights were cross-checked against recognized clinical and policy references to avoid unsupported assumptions and to ensure that the conclusions reflect verifiable trends in anatomic pathology, digital pathology, AI-enabled diagnostics, laboratory automation, and precision oncology.

Conclusion: The Future of Anatomic Pathology

Anatomic pathology is evolving from a predominantly manual diagnostic specialty into an integrated, digitally enabled, and biomarker-driven foundation of precision medicine. Rising cancer incidence, expanding tissue-based testing, and growing demand for faster and more reproducible diagnoses are strengthening its role across healthcare systems.

The next phase of leadership will favor organizations that combine scientific rigor, workflow efficiency, regulatory readiness, interoperability, and responsible AI adoption. Laboratories, technology vendors, and healthcare providers that align innovation with quality, access, data security, and clinical trust will be best positioned to create long-term value in global anatomic pathology.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Anatomic Pathology Market, by Product
7.1. Introduction
7.2. Instruments & Equipment
7.2.1. Slide-Staining Systems
7.2.2. Tissue Processing Systems
7.2.3. Embedding Systems
7.2.4. Microtomes
7.2.5. Pathology Scanners
7.2.6. Microscopes
7.2.7. Grossing Stations
7.2.8. Tissue Homogenizers
7.3. Reagents & Consumables
7.3.1. Antibodies & Reagents
7.3.2. Kits
7.3.3. Slides & Coverslips
7.3.4. Cassettes & Embedding Media
7.4. Services
7.4.1. Reference Laboratory Services
7.4.2. Maintenance & Support
7.5. Software & Analysis Tools
7.5.1. Image Analysis Software
7.5.2. Laboratory Information Systems
7.5.3. Pathology Viewers
8. Anatomic Pathology Market, by Technology
8.1. Introduction
8.2. Digital Pathology
8.3. Immunohistochemistry
8.4. In Situ Hybridization
8.5. Molecular Diagnostics
8.6. Special Staining
9. Anatomic Pathology Market, by Workflow Stage
9.1. Introduction
9.2. Specimen Pre-Analytics
9.3. Tissue Processing & Embedding
9.4. Microtomy
9.5. Staining & Labeling
9.6. Image Analysis
9.7. Interpretation & Reporting
10. Anatomic Pathology Market, by Application
10.1. Introduction
10.2. Disease Diagnosis
10.2.1. Cancer
10.2.2. Infectious Diseases
10.2.3. Neurological Disorders
10.2.4. Cardiovascular Diseases
10.3. Drug Discovery & Development
10.4. Academic & Research
11. Anatomic Pathology Market, by End User
11.1. Introduction
11.2. Hospitals
11.3. Diagnostic Laboratories
11.4. Ambulatory Surgical Centers
11.5. Pharmaceuticals & Biotechnology Companies
11.6. Academic & Research Institutes
12. Anatomic Pathology Market, by Region
12.1. Europe
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Middle East
12.6. Africa
13. Anatomic Pathology Market, by Group
13.1. NATO
13.2. G7
13.3. European Union
13.4. BRICS
13.5. ASEAN
13.6. GCC
14. Anatomic Pathology Market, by Country
14.1. United States
14.2. China
14.3. Germany
14.4. Japan
14.5. India
14.6. United Kingdom
14.7. France
14.8. South Korea
14.9. Canada
14.10. Australia
14.11. Italy
14.12. Brazil
14.13. Spain
14.14. Russia
14.15. Mexico
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. FPNV Positioning Matrix, 2025
15.3. Market Concentration Analysis, 2025
15.3.1. Concentration Ratio (CR)
15.3.2. Herfindahl Hirschman Index (HHI)
15.4. Recent Developments & Impact Analysis, 2025
15.5. Product Portfolio Analysis, 2025
15.6. Benchmarking Analysis, 2025
16. Company Profiles
16.1. F. Hoffmann-La Roche Ltd
16.2. Danaher Corporation
16.3. Labcorp Holdings Inc.
16.4. Sonic Healthcare Limited
16.5. Quest Diagnostics Incorporated
16.6. Agilent Technologies, Inc.
16.7. SYNLAB AG
16.8. PHC Holdings Corporation
16.9. Siemens Healthineers AG
16.10. BIOMERIEUX
16.11. Neogenomics Laboratories, Inc.
16.12. Sysmex Corporation
16.13. Abbott Laboratories
16.14. Hologic, Inc.
16.15. ARUP Laboratories
16.16. Avantik
16.17. Bio-Techne Corporation
16.18. Biocare Medical, LLC
16.19. Cardinal Health
16.20. Cell Signaling Technology, Inc.
16.21. Cerba Research NV
16.22. Charles River Laboratories International, Inc.
16.23. Epredia
16.24. FUJIFILM Holdings Corporation
16.25. GPI S.p.A.
16.26. Guardant Health, Inc.
16.27. Healthscope Ltd.
16.28. Inpeco SA
16.29. Koninklijke Philips N.V.
16.30. LigoLab Information Systems
16.31. Milestone SPA
16.32. Molecular Pathology Laboratory Network, Inc.
16.33. Propath UK Limited
16.34. Proscia Inc.
16.35. Sakura Seiki Co., Ltd.
16.36. Techcyte, Inc.
16.37. Unilabs SA
16.38. Veracyte, Inc.
16.39. Visiant Health
List of Figures
FIGURE 1. GLOBAL ANATOMIC PATHOLOGY MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL ANATOMIC PATHOLOGY MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL ANATOMIC PATHOLOGY MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL ANATOMIC PATHOLOGY MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL ANATOMIC PATHOLOGY MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL ANATOMIC PATHOLOGY MARKET SIZE, BY PRODUCT, 2025 VS 2032 (%)
FIGURE 7. GLOBAL ANATOMIC PATHOLOGY MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ANATOMIC PATHOLOGY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 9. GLOBAL ANATOMIC PATHOLOGY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL ANATOMIC PATHOLOGY MARKET SIZE, BY WORKFLOW STAGE, 2025 VS 2032 (%)
FIGURE 11. GLOBAL ANATOMIC PATHOLOGY MARKET SIZE, BY WORKFLOW STAGE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL ANATOMIC PATHOLOGY MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 13. GLOBAL ANATOMIC PATHOLOGY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL ANATOMIC PATHOLOGY MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 15. GLOBAL ANATOMIC PATHOLOGY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL ANATOMIC PATHOLOGY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL ANATOMIC PATHOLOGY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL ANATOMIC PATHOLOGY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 19. GLOBAL ANATOMIC PATHOLOGY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL ANATOMIC PATHOLOGY MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL ANATOMIC PATHOLOGY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL ANATOMIC PATHOLOGY MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 23. GLOBAL ANATOMIC PATHOLOGY MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL ANATOMIC PATHOLOGY MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL ANATOMIC PATHOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL ANATOMIC PATHOLOGY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL INSTRUMENTS & EQUIPMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL INSTRUMENTS & EQUIPMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL INSTRUMENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL SLIDE-STAINING SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL SLIDE-STAINING SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL SLIDE-STAINING SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL TISSUE PROCESSING SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL TISSUE PROCESSING SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL TISSUE PROCESSING SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL EMBEDDING SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL EMBEDDING SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL EMBEDDING SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL MICROTOMES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL MICROTOMES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL MICROTOMES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL PATHOLOGY SCANNERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL PATHOLOGY SCANNERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL PATHOLOGY SCANNERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL MICROSCOPES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL MICROSCOPES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL MICROSCOPES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL GROSSING STATIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL GROSSING STATIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL GROSSING STATIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL TISSUE HOMOGENIZERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL TISSUE HOMOGENIZERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL TISSUE HOMOGENIZERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL REAGENTS & CONSUMABLES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL REAGENTS & CONSUMABLES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL REAGENTS & CONSUMABLES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL ANTIBODIES & REAGENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL ANTIBODIES & REAGENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL ANTIBODIES & REAGENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL SLIDES & COVERSLIPS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL SLIDES & COVERSLIPS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL SLIDES & COVERSLIPS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL CASSETTES & EMBEDDING MEDIA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL CASSETTES & EMBEDDING MEDIA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL CASSETTES & EMBEDDING MEDIA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL REFERENCE LABORATORY SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL REFERENCE LABORATORY SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL REFERENCE LABORATORY SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL MAINTENANCE & SUPPORT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL MAINTENANCE & SUPPORT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL MAINTENANCE & SUPPORT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL SOFTWARE & ANALYSIS TOOLS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL SOFTWARE & ANALYSIS TOOLS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL SOFTWARE & ANALYSIS TOOLS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL LABORATORY INFORMATION SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL LABORATORY INFORMATION SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL LABORATORY INFORMATION SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL PATHOLOGY VIEWERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL PATHOLOGY VIEWERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL PATHOLOGY VIEWERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL ANATOMIC PATHOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL SPECIAL STAINING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL SPECIAL STAINING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL SPECIAL STAINING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL ANATOMIC PATHOLOGY MARKET SIZE, BY WORKFLOW STAGE, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL SPECIMEN PRE-ANALYTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL SPECIMEN PRE-ANALYTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL SPECIMEN PRE-ANALYTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL TISSUE PROCESSING & EMBEDDING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL TISSUE PROCESSING & EMBEDDING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL TISSUE PROCESSING & EMBEDDING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL MICROTOMY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL MICROTOMY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL MICROTOMY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL STAINING & LABELING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL STAINING & LABELING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL STAINING & LABELING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL IMAGE ANALYSIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL IMAGE ANALYSIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL IMAGE ANALYSIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL INTERPRETATION & REPORTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL INTERPRETATION & REPORTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL INTERPRETATION & REPORTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL ANATOMIC PATHOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL DISEASE DIAGNOSIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL DISEASE DIAGNOSIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL DISEASE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL CANCER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL CANCER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL CANCER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 114. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 115. GLOBAL CARDIOVASCULAR DISEASES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 116. GLOBAL CARDIOVASCULAR DISEASES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 117. GLOBAL CARDIOVASCULAR DISEASES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 118. GLOBAL DRUG DISCOVERY & DEVELOPMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 119. GLOBAL DRUG DISCOVERY & DEVELOPMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 120. GLOBAL DRUG DISCOVERY & DEVELOPMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 121. GLOBAL ACADEMIC & RESEARCH MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 122. GLOBAL ACADEMIC & RESEARCH MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 123. GLOBAL ACADEMIC & RESEARCH MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 124. GLOBAL ANATOMIC PATHOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 125. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 126. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 127. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 128. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 129. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 130. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 131. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 132. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 133. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 134. GLOBAL PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 135. GLOBAL PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 136. GLOBAL PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 137. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 138. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 139. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 140. GLOBAL ANATOMIC PATHOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 141. EUROPE ANATOMIC PATHOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 142. EUROPE ANATOMIC PATHOLOGY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 143. EUROPE ANATOMIC PATHOLOGY MARKET SIZE, BY INSTRUMENTS & EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 144. EUROPE ANATOMIC PATHOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 145. EUROPE ANATOMIC PATHOLOGY MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 146. EUROPE ANATOMIC PATHOLOGY MARKET SIZE, BY SOFTWARE & ANALYSIS TOOLS, 2017-2032 (USD MILLION)
TABLE 147. EUROPE ANATOMIC PATHOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 148. EUROPE ANATOMIC PATHOLOGY MARKET SIZE, BY WORKFLOW STAGE, 2017-2032 (USD MILLION)
TABLE 149. EUROPE ANATOMIC PATHOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 150. EUROPE ANATOMIC PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2017-2032 (USD MILLION)
TABLE 151. EUROPE ANATOMIC PATHOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 152. ASIA-PACIFIC ANATOMIC PATHOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 153. ASIA-PACIFIC ANATOMIC PATHOLOGY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 154. ASIA-PACIFIC ANATOMIC PATHOLOGY MARKET SIZE, BY INSTRUMENTS & EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 155. ASIA-PACIFIC ANATOMIC PATHOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 156. ASIA-PACIFIC ANATOMIC PATHOLOGY MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 157. ASIA-PACIFIC ANATOMIC PATHOLOGY MARKET SIZE, BY SOFTWARE & ANALYSIS TOOLS, 2017-2032 (USD MILLION)
TABLE 158. ASIA-PACIFIC ANATOMIC PATHOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 159. ASIA-PACIFIC ANATOMIC PATHOLOGY MARKET SIZE, BY WORKFLOW STAGE, 2017-2032 (USD MILLION)
TABLE 160. ASIA-PACIFIC ANATOMIC PATHOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 161. ASIA-PACIFIC ANATOMIC PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2017-2032 (USD MILLION)
TABLE 162. ASIA-PACIFIC ANATOMIC PATHOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 163. NORTH AMERICA ANATOMIC PATHOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 164. NORTH AMERICA ANATOMIC PATHOLOGY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 165. NORTH AMERICA ANATOMIC PATHOLOGY MARKET SIZE, BY INSTRUMENTS & EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 166. NORTH AMERICA ANATOMIC PATHOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 167. NORTH AMERICA ANATOMIC PATHOLOGY MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 168. NORTH AMERICA ANATOMIC PATHOLOGY MARKET SIZE, BY SOFTWARE & ANALYSIS TOOLS, 2017-2032 (USD MILLION)
TABLE 169. NORTH AMERICA ANATOMIC PATHOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 170. NORTH AMERICA ANATOMIC PATHOLOGY MARKET SIZE, BY WORKFLOW STAGE, 2017-2032 (USD MILLION)
TABLE 171. NORTH AMERICA ANATOMIC PATHOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 172. NORTH AMERICA ANATOMIC PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2017-2032 (USD MILLION)
TABLE 173. NORTH AMERICA ANATOMIC PATHOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 174. LATIN AMERICA ANATOMIC PATHOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 175. LATIN AMERICA ANATOMIC PATHOLOGY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 176. LATIN AMERICA ANATOMIC PATHOLOGY MARKET SIZE, BY INSTRUMENTS & EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 177. LATIN AMERICA ANATOMIC PATHOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 178. LATIN AMERICA ANATOMIC PATHOLOGY MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 179. LATIN AMERICA ANATOMIC PATHOLOGY MARKET SIZE, BY SOFTWARE & ANALYSIS TOOLS, 2017-2032 (USD MILLION)
TABLE 180. LATIN AMERICA ANATOMIC PATHOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 181. LATIN AMERICA ANATOMIC PATHOLOGY MARKET SIZE, BY WORKFLOW STAGE, 2017-2032 (USD MILLION)
TABLE 182. LATIN AMERICA ANATOMIC PATHOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 183. LATIN AMERICA ANATOMIC PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2017-2032 (USD MILLION)
TABLE 184. LATIN AMERICA ANATOMIC PATHOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 185. MIDDLE EAST ANATOMIC PATHOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 186. MIDDLE EAST ANATOMIC PATHOLOGY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 187. MIDDLE EAST ANATOMIC PATHOLOGY MARKET SIZE, BY INSTRUMENTS & EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 188. MIDDLE EAST ANATOMIC PATHOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 189. MIDDLE EAST ANATOMIC PATHOLOGY MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 190. MIDDLE EAST ANATOMIC PATHOLOGY MARKET SIZE, BY SOFTWARE & ANALYSIS TOOLS, 2017-2032 (USD MILLION)
TABLE 191. MIDDLE EAST ANATOMIC PATHOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 192. MIDDLE EAST ANATOMIC PATHOLOGY MARKET SIZE, BY WORKFLOW STAGE, 2017-2032 (USD MILLION)
TABLE 193. MIDDLE EAST ANATOMIC PATHOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 194. MIDDLE EAST ANATOMIC PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2017-2032 (USD MILLION)
TABLE 195. MIDDLE EAST ANATOMIC PATHOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 196. AFRICA ANATOMIC PATHOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 197. AFRICA ANATOMIC PATHOLOGY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 198. AFRICA ANATOMIC PATHOLOGY MARKET SIZE, BY INSTRUMENTS & EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 199. AFRICA ANATOMIC PATHOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 200. AFRICA ANATOMIC PATHOLOGY MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 201. AFRICA ANATOMIC PATHOLOGY MARKET SIZE, BY SOFTWARE & ANALYSIS TOOLS, 2017-2032 (USD MILLION)
TABLE 202. AFRICA ANATOMIC PATHOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 203. AFRICA ANATOMIC PATHOLOGY MARKET SIZE, BY WORKFLOW STAGE, 2017-2032 (USD MILLION)
TABLE 204. AFRICA ANATOMIC PATHOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 205. AFRICA ANATOMIC PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2017-2032 (USD MILLION)
TABLE 206. AFRICA ANATOMIC PATHOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 207. GLOBAL ANATOMIC PATHOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 208. NATO ANATOMIC PATHOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 209. NATO ANATOMIC PATHOLOGY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 210. NATO ANATOMIC PATHOLOGY MARKET SIZE, BY INSTRUMENTS & EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 211. NATO ANATOMIC PATHOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 212. NATO ANATOMIC PATHOLOGY MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 213. NATO ANATOMIC PATHOLOGY MARKET SIZE, BY SOFTWARE & ANALYSIS TOOLS, 2017-2032 (USD MILLION)
TABLE 214. NATO ANATOMIC PATHOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 215. NATO ANATOMIC PATHOLOGY MARKET SIZE, BY WORKFLOW STAGE, 2017-2032 (USD MILLION)
TABLE 216. NATO ANATOMIC PATHOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 217. NATO ANATOMIC PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2017-2032 (USD MILLION)
TABLE 218. NATO ANATOMIC PATHOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 219. G7 ANATOMIC PATHOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 220. G7 ANATOMIC PATHOLOGY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 221. G7 ANATOMIC PATHOLOGY MARKET SIZE, BY INSTRUMENTS & EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 222. G7 ANATOMIC PATHOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 223. G7 ANATOMIC PATHOLOGY MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 224. G7 ANATOMIC PATHOLOGY MARKET SIZE, BY SOFTWARE & ANALYSIS TOOLS, 2017-2032 (USD MILLION)
TABLE 225. G7 ANATOMIC PATHOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 226. G7 ANATOMIC PATHOLOGY MARKET SIZE, BY WORKFLOW STAGE, 2017-2032 (USD MILLION)
TABLE 227. G7 ANATOMIC PATHOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 228. G7 ANATOMIC PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2017-2032 (USD MILLION)
TABLE 229. G7 ANATOMIC PATHOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 230. EUROPEAN UNION ANATOMIC PATHOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 231. EUROPEAN UNION ANATOMIC PATHOLOGY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 232. EUROPEAN UNION ANATOMIC PATHOLOGY MARKET SIZE, BY INSTRUMENTS & EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 233. EUROPEAN UNION ANATOMIC PATHOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 234. EUROPEAN UNION ANATOMIC PATHOLOGY MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 235. EUROPEAN UNION ANATOMIC PATHOLOGY MARKET SIZE, BY SOFTWARE & ANALYSIS TOOLS, 2017-2032 (USD MILLION)
TABLE 236. EUROPEAN UNION ANATOMIC PATHOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 237. EUROPEAN UNION ANATOMIC PATHOLOGY MARKET SIZE, BY WORKFLOW STAGE, 2017-2032 (USD MILLION)
TABLE 238. EUROPEAN UNION ANATOMIC PATHOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 239. EUROPEAN UNION ANATOMIC PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2017-2032 (USD MILLION)
TABLE 240. EUROPEAN UNION ANATOMIC PATHOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 241. BRICS ANATOMIC PATHOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 242. BRICS ANATOMIC PATHOLOGY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 243. BRICS ANATOMIC PATHOLOGY MARKET SIZE, BY INSTRUMENTS & EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 244. BRICS ANATOMIC PATHOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 245. BRICS ANATOMIC PATHOLOGY MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 246. BRICS ANATOMIC PATHOLOGY MARKET SIZE, BY SOFTWARE & ANALYSIS TOOLS, 2017-2032 (USD MILLION)
TABLE 247. BRICS ANATOMIC PATHOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 248. BRICS ANATOMIC PATHOLOGY MARKET SIZE, BY WORKFLOW STAGE, 2017-2032 (USD MILLION)
TABLE 249. BRICS ANATOMIC PATHOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 250. BRICS ANATOMIC PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2017-2032 (USD MILLION)
TABLE 251. BRICS ANATOMIC PATHOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 252. ASEAN ANATOMIC PATHOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 253. ASEAN ANATOMIC PATHOLOGY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 254. ASEAN ANATOMIC PATHOLOGY MARKET SIZE, BY INSTRUMENTS & EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 255. ASEAN ANATOMIC PATHOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 256. ASEAN ANATOMIC PATHOLOGY MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 257. ASEAN ANATOMIC PATHOLOGY MARKET SIZE, BY SOFTWARE & ANALYSIS TOOLS, 2017-2032 (USD MILLION)
TABLE 258. ASEAN ANATOMIC PATHOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 259. ASEAN ANATOMIC PATHOLOGY MARKET SIZE, BY WORKFLOW STAGE, 2017-2032 (USD MILLION)
TABLE 260. ASEAN ANATOMIC PATHOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 261. ASEAN ANATOMIC PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2017-2032 (USD MILLION)
TABLE 262. ASEAN ANATOMIC PATHOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 263. GCC ANATOMIC PATHOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 264. GCC ANATOMIC PATHOLOGY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 265. GCC ANATOMIC PATHOLOGY MARKET SIZE, BY INSTRUMENTS & EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 266. GCC ANATOMIC PATHOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 267. GCC ANATOMIC PATHOLOGY MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 268. GCC ANATOMIC PATHOLOGY MARKET SIZE, BY SOFTWARE & ANALYSIS TOOLS, 2017-2032 (USD MILLION)
TABLE 269. GCC ANATOMIC PATHOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 270. GCC ANATOMIC PATHOLOGY MARKET SIZE, BY WORKFLOW STAGE, 2017-2032 (USD MILLION)
TABLE 271. GCC ANATOMIC PATHOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 272. GCC ANATOMIC PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2017-2032 (USD MILLION)
TABLE 273. GCC ANATOMIC PATHOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 274. GLOBAL ANATOMIC PATHOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 275. UNITED STATES ANATOMIC PATHOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 276. UNITED STATES ANATOMIC PATHOLOGY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 277. UNITED STATES ANATOMIC PATHOLOGY MARKET SIZE, BY INSTRUMENTS & EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 278. UNITED STATES ANATOMIC PATHOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 279. UNITED STATES ANATOMIC PATHOLOGY MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 280. UNITED STATES ANATOMIC PATHOLOGY MARKET SIZE, BY SOFTWARE & ANALYSIS TOOLS, 2017-2032 (USD MILLION)
TABLE 281. UNITED STATES ANATOMIC PATHOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 282. UNITED STATES ANATOMIC PATHOLOGY MARKET SIZE, BY WORKFLOW STAGE, 2017-2032 (USD MILLION)
TABLE 283. UNITED STATES ANATOMIC PATHOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 284. UNITED STATES ANATOMIC PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2017-2032 (USD MILLION)
TABLE 285. UNITED STATES ANATOMIC PATHOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 286. CHINA ANATOMIC PATHOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 287. CHINA ANATOMIC PATHOLOGY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 288. CHINA ANATOMIC PATHOLOGY MARKET SIZE, BY INSTRUMENTS & EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 289. CHINA ANATOMIC PATHOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 290. CHINA ANATOMIC PATHOLOGY MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 291. CHINA ANATOMIC PATHOLOGY MARKET SIZE, BY SOFTWARE & ANALYSIS TOOLS, 2017-2032 (USD MILLION)
TABLE 292. CHINA ANATOMIC PATHOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 293. CHINA ANATOMIC PATHOLOGY MARKET SIZE, BY WORKFLOW STAGE, 2017-2032 (USD MILLION)
TABLE 294. CHINA ANATOMIC PATHOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 295. CHINA ANATOMIC PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2017-2032 (USD MILLION)
TABLE 296. CHINA ANATOMIC PATHOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 297. GERMANY ANATOMIC PATHOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 298. GERMANY ANATOMIC PATHOLOGY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 299. GERMANY ANATOMIC PATHOLOGY MARKET SIZE, BY INSTRUMENTS & EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 300. GERMANY ANATOMIC PATHOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 301. GERMANY ANATOMIC PATHOLOGY MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 302. GERMANY ANATOMIC PATHOLOGY MARKET SIZE, BY SOFTWARE & ANALYSIS TOOLS, 2017-2032 (USD MILLION)
TABLE 303. GERMANY ANATOMIC PATHOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 304. GERMANY ANATOMIC PATHOLOGY MARKET SIZE, BY WORKFLOW STAGE, 2017-2032 (USD MILLION)
TABLE 305. GERMANY ANATOMIC PATHOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 306. GERMANY ANATOMIC PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2017-2032 (USD MILLION)
TABLE 307. GERMANY ANATOMIC PATHOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 308. JAPAN ANATOMIC PATHOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 309. JAPAN ANATOMIC PATHOLOGY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 310. JAPAN ANATOMIC PATHOLOGY MARKET SIZE, BY INSTRUMENTS & EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 311. JAPAN ANATOMIC PATHOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 312. JAPAN ANATOMIC PATHOLOGY MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 313. JAPAN ANATOMIC PATHOLOGY MARKET SIZE, BY SOFTWARE & ANALYSIS TOOLS, 2017-2032 (USD MILLION)
TABLE 314. JAPAN ANATOMIC PATHOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 315. JAPAN ANATOMIC PATHOLOGY MARKET SIZE, BY WORKFLOW STAGE, 2017-2032 (USD MILLION)
TABLE 316. JAPAN ANATOMIC PATHOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 317. JAPAN ANATOMIC PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2017-2032 (USD MILLION)
TABLE 318. JAPAN ANATOMIC PATHOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 319. INDIA ANATOMIC PATHOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 320. INDIA ANATOMIC PATHOLOGY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 321. INDIA ANATOMIC PATHOLOGY MARKET SIZE, BY INSTRUMENTS & EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 322. INDIA ANATOMIC PATHOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 323. INDIA ANATOMIC PATHOLOGY MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 324. INDIA ANATOMIC PATHOLOGY MARKET SIZE, BY SOFTWARE & ANALYSIS TOOLS, 2017-2032 (USD MILLION)
TABLE 325. INDIA ANATOMIC PATHOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 326. INDIA ANATOMIC PATHOLOGY MARKET SIZE, BY WORKFLOW STAGE, 2017-2032 (USD MILLION)
TABLE 327. INDIA ANATOMIC PATHOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 328. INDIA ANATOMIC PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2017-2032 (USD MILLION)
TABLE 329. INDIA ANATOMIC PATHOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 330. UNITED KINGDOM ANATOMIC PATHOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 331. UNITED KINGDOM ANATOMIC PATHOLOGY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 332. UNITED KINGDOM ANATOMIC PATHOLOGY MARKET SIZE, BY INSTRUMENTS & EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 333. UNITED KINGDOM ANATOMIC PATHOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 334. UNITED KINGDOM ANATOMIC PATHOLOGY MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 335. UNITED KINGDOM ANATOMIC PATHOLOGY MARKET SIZE, BY SOFTWARE & ANALYSIS TOOLS, 2017-2032 (USD MILLION)
TABLE 336. UNITED KINGDOM ANATOMIC PATHOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 337. UNITED KINGDOM ANATOMIC PATHOLOGY MARKET SIZE, BY WORKFLOW STAGE, 2017-2032 (USD MILLION)
TABLE 338. UNITED KINGDOM ANATOMIC PATHOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 339. UNITED KINGDOM ANATOMIC PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2017-2032 (USD MILLION)
TABLE 340. UNITED KINGDOM ANATOMIC PATHOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 341. FRANCE ANATOMIC PATHOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 342. FRANCE ANATOMIC PATHOLOGY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 343. FRANCE ANATOMIC PATHOLOGY MARKET SIZE, BY INSTRUMENTS & EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 344. FRANCE ANATOMIC PATHOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 345. FRANCE ANATOMIC PATHOLOGY MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 346. FRANCE ANATOMIC PATHOLOGY MARKET SIZE, BY SOFTWARE & ANALYSIS TOOLS, 2017-2032 (USD MILLION)
TABLE 347. FRANCE ANATOMIC PATHOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 348. FRANCE ANATOMIC PATHOLOGY MARKET SIZE, BY WORKFLOW STAGE, 2017-2032 (USD MILLION)
TABLE 349. FRANCE ANATOMIC PATHOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 350. FRANCE ANATOMIC PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2017-2032 (USD MILLION)
TABLE 351. FRANCE ANATOMIC PATHOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 352. SOUTH KOREA ANATOMIC PATHOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 353. SOUTH KOREA ANATOMIC PATHOLOGY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 354. SOUTH KOREA ANATOMIC PATHOLOGY MARKET SIZE, BY INSTRUMENTS & EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 355. SOUTH KOREA ANATOMIC PATHOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 356. SOUTH KOREA ANATOMIC PATHOLOGY MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 357. SOUTH KOREA ANATOMIC PATHOLOGY MARKET SIZE, BY SOFTWARE & ANALYSIS TOOLS, 2017-2032 (USD MILLION)
TABLE 358. SOUTH KOREA ANATOMIC PATHOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 359. SOUTH KOREA ANATOMIC PATHOLOGY MARKET SIZE, BY WORKFLOW STAGE, 2017-2032 (USD MILLION)
TABLE 360. SOUTH KOREA ANATOMIC PATHOLOGY MARKET SIZE, BY APPLICATION,

Companies Mentioned

  • F. Hoffmann-La Roche Ltd
  • Danaher Corporation
  • Labcorp Holdings Inc.
  • Sonic Healthcare Limited
  • Quest Diagnostics Incorporated
  • Agilent Technologies, Inc.
  • SYNLAB AG
  • PHC Holdings Corporation
  • Siemens Healthineers AG
  • BIOMERIEUX
  • Neogenomics Laboratories, Inc.
  • Sysmex Corporation
  • Abbott Laboratories
  • Hologic, Inc.
  • ARUP Laboratories
  • Avantik
  • Bio-Techne Corporation
  • Biocare Medical, LLC
  • Cardinal Health
  • Cell Signaling Technology, Inc.
  • Cerba Research NV
  • Charles River Laboratories International, Inc.
  • Epredia
  • FUJIFILM Holdings Corporation
  • GPI S.p.A.
  • Guardant Health, Inc.
  • Healthscope Ltd.
  • Inpeco SA
  • Koninklijke Philips N.V.
  • LigoLab Information Systems
  • Milestone SPA
  • Molecular Pathology Laboratory Network, Inc.
  • Propath UK Limited
  • Proscia Inc.
  • Sakura Seiki Co., Ltd.
  • Techcyte, Inc.
  • Unilabs SA
  • Veracyte, Inc.
  • Visiant Health

Table Information

Report AttributeDetails
No. of Pages189
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 44.8 Billion
Forecasted Market Value ( USD ) by 2032 $ 75.43 Billion
Compound Annual Growth Rate8.9%
Regions CoveredGlobal
No. of Companies Mentioned39

Related Topics

Related Reports

Anatomic Pathology Testing Market - Global Forecast 2026-2032 - Product Image

Anatomic Pathology Testing Market - Global Forecast 2026-2032

  • Report
  • 183 Pages
  • Global
From
Anatomic Pathology Track & Trace Solution Market - Global Forecast 2026-2032 - Product Image

Anatomic Pathology Track & Trace Solution Market - Global Forecast 2026-2032

  • Report
  • 183 Pages
  • Global
From
Anatomic Pathology Market - Products and Applications - Product Image

Anatomic Pathology Market - Products and Applications

  • Report
  • 256 Pages
  • Global
From
Anatomic Pathology - Global Strategic Business Report - Product Image

Anatomic Pathology - Global Strategic Business Report

  • Report
  • 377 Pages
  • Global
From
Anatomic Pathology Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Image

Anatomic Pathology Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • 110 Pages
  • Global
From

About the Market

The Anatomic Pathology market within the context of In Vitro Diagnostics is a specialized field of medicine that focuses on the diagnosis and characterization of diseases through the examination of tissue samples. It is a key component of the In Vitro Diagnostics industry, as it provides the necessary information to accurately diagnose and treat diseases. Anatomic Pathology is used to detect and diagnose a wide range of diseases, including cancer, infectious diseases, and genetic disorders. It is also used to monitor the progression of diseases and to assess the effectiveness of treatments. Anatomic Pathology is a highly specialized field, and requires specialized equipment and expertise. It is typically performed in a laboratory setting, and requires the use of sophisticated instruments such as microscopes, automated staining systems, and digital imaging systems. Some of the major companies in the Anatomic Pathology market include Agilent Technologies, Abbott Laboratories, Becton Dickinson, Roche Diagnostics, and Thermo Fisher Scientific. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.